1) MRI signal intensity
MRI信号强度
1.
Results The correlation coefficient(r)between the ratio of the MRI signal intensity and the Aggrecan content in the discs of GradeⅠ,Ⅱ and Ⅲ were 0.
目的探讨退行性变腰椎间盘MRI信号强度和聚集蛋白聚糖(aggrecan)含量之间的相关性。
2) signal strength
信号强度
1.
LSSVR target localization method in WSN modeling on signal strength difference to eliminate the target power influence
消除WSN目标功率影响的信号强度差LSSVR定位法
2.
Matching location based on signal strength is the primary method of Wireless LAN(WLAN) location, which includes offline training phase and online location determination phase.
基于信号强度的匹配定位是无线网络定位的主要方法,包括离线训练和在线定位2个阶段。
3.
In this paper,average Packet Loss Rate(PLR) and signal strength of the wireless link are measured.
该文对不同环境下无线链路丢包率、信号强度等参数进行了测量和分析。
3) signal intensity
信号强度
1.
A method for determining NMR log signal intensity;
一种核磁共振测井信号强度的确定方法
2.
Effect of Incidence of the Signal Light and Splitter on Heterodyne Signal Intensity;
信号光的入射角和分光片对激光外差干涉信号强度的影响
3.
The signal intensity(SI) ratio of pancreas relative to liver and spleen was quantitatively measured using regions of interest(ROIs),then qualitatively assessed by one independent observers.
方法对92例研究对象行脂肪抑制FSPGR序列扫描,其中57例正常胰腺,35例异常胰腺,测量RO I的信号强度,并计算胰腺相对于肝脏、脾脏的信号强度比值,然后进行定性评价。
4) signal intensity ratio
信号强度比
1.
The signal intensity ratios(SIR,signal intensity at opposed-phase over signal intensity at in-phase) were calculated and compared among these conditions.
方法:回顾分析本院126例脊柱病变患者,包括31例恶性椎体肿瘤、38例急性椎体良性压缩性骨折、8例血管瘤、26例终板退变、18例局灶性骨髓脂肪变性及5例脊柱感染,计算各种病变正反回波的信号强度比(反相位/正相位,SIR),并对各组病例作对比和分析。
2.
ObjectiveTo explore the accuracy and clinical value of the MRI quantitative diagnostic,which are liver / muscle signal intensity ratio and T2 values in vitro iron concentration and liver iron deposition.
目的利用MRI肝脏/肌肉信号强度比值及肝脏T2值测定技术,探讨体外铁浓度及肝脏铁沉积的MRI定量诊断的准确性及临床应用价值。
5) ESR signal intensity
ESR信号强度
补充资料：[3-(aminosulfonyl)-4-chloro-N-(2.3-dihydro-2-methyl-1H-indol-1-yl)benzamide]
分子式：C16H16ClN3O3S
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条